Skip to main content

To Our Valued Patients,

With the evolving situation of the Coronavirus (COVID-19) pandemic, effective immediately, we will be suspending all non-urgent eye care. Moreover, any non-emergent or elective surgery will also have to be postponed. We will continue to remain open for patients with urgent and emergent concerns only. It is important to us to keep these patients out of the emergency room so our healthcare heroes on the front lines can be available for the patients that need them the most.

Our staff will continue to answer calls and scheduling appointments to the best of their ability.  In addition, if appropriate, Dr Patel can be available for telemedicine visits via online video chat. If you would like to schedule a telemedicine appointment with Dr. Patel, please call our office first to determine eligibility and to obtain an appointment time. Instructions for how to connect to the telemedicine appointment will be given at that time.

We hope to see you back in our office in the not too distant future. Stay safe and stay healthy!

The Turner Eye Institute Team

Book Exam
Call Us

With offices in San Leandro, Concord
and Castro Valley

Home » What's New » Information on Fusarium Keratitis for KFAX listeners

Information on Fusarium Keratitis for KFAX listeners

Latest case numbers

From the U.S. Centers for Disease Control and Prevention (CDC):

  • 106 confirmed cases of Fusarium keratitis
  • 12 “possible” cases and 80 still under investigation
  • Confirmed cases or cases under investigation reported in 32 states or territories (see list below).

What products were used in Fusarium keratitis cases (from the CDC, May 9):

  • Complete data are available on 98 confirmed. Of those 98, 93 (95 percent) were listed as a contact lens user.
  • The products reported used in those 93:
    • 59 (66 percent) – Bausch & Lomb ReNu with MoistureLoc
    • 19 (21 percent) - Bausch & Lomb ReNu MultiPlus
    • 9 (10 percent) – Bausch & Lomb ReNu (unspecified)
    • 3 (3 percent) - any Advanced Medical Optics (AMO) product
    • 4 (4 percent) – any Alcon product

Helpful links:
American Academy of Ophthalmology Web Site

US Food and Drug Administration Web Site

Centers for Disease Control and Prevention Web Site

Bausch and Lomb Company Web Site